Menu menu
  • Flux RSS
  • Twitter
  • Facebook
  • Google Plus
  • LinkedIn
Newsletter - April 2016

Newsletter - April 2016

Read our latest newsletter → Visit the (...)

Genopole's Business Support

Genopole’s Business Support

The leading biotech and biotherapy cluster

The leading biotech and biotherapy cluster

Synthetic and systems biology

Synthetic and systems biology

Our real estate offer

Our real estate offer

A medical environment

A medical environment

All Videos of Biomaths Conference

All Videos of Biomaths Conference

Genobiomedecine, a path toward personalized treatments

Genobiomedecine, a path toward personalized treatments

Agenda

08.09

BIOREGATE. European Regenerative Medicine Forum

Bioregate Forum is a great opportunity to present and discuss your company’s or organisation’s latest achievements in research, innovation, clinical trials or market access approaches. The (...)

Read more

27.06

WIN 2016 Symposium

“Innovative Approaches to Improve Cancer Patient Outcomes” It is the 8th edition of a successful series of symposia organized by the Worldwide Innovative Networking (WIN) Consortium, dedicated to (...)

Read more

12.06

International Congress on Personalized Health Care

Personalized Health Care: From Research to Impact Palais des Congrès de Montréal At the dawn of the twenty-first century, the most recent research in molecular biology, advances in genomics, and (...)

Read more

Live news

  • Genopole

    23 May 2016

    Thierry Mandon : "Notre machine à décider tourne dans le vide" - leJDD.fr https://t.co/NlZiMNFWsK

  • Genopole

    23 May 2016

    RT @AnovaPlus: Observations du public pour le plan de lutte régional Flavescence Dorée 2016 en PACA : https://t.co/KrgI5ArNx2

  • Genopole

    23 May 2016

    @TBiScientific @Genopole https://t.co/hkqCc0V5OC

  • Genopole

    23 May 2016

    VIH : feu vert de la FDA pour un essai clinique de phase 2 de VAC-3S @InnaVirVax aux USA https://t.co/rDbGoNXhKD

  • Genopole

    23 May 2016

    RT @GlobalBioenergi: #GlobalBioenergies $ALGBE livre un lot #isobutène à Arlanxeo @Saudi_Aramco @LANXESS dans @LesEchos par @RoussangeG htt…

  • Genopole

    23 May 2016

    VitaDX cherche 1,5 M€ pour son diagnostic du cancer de la vessie https://t.co/b041NPacBf

  • Genopole

    23 May 2016

    Texcell @genopole spécialiste en sécurité virale, immunologie rachète l'allemand Vivo Science https://t.co/Y7rHM8oSS0

  • Genopole

    23 May 2016

    Cure for HIV gets closer as researchers snip virus out of cells https://t.co/sywUi14amA via @TIMEHealth

  • Genopole

    23 May 2016

    Global Bioenergies est prêt à prendre pied sur le marché des caoutchoucs verts https://t.co/5E76EUtbsR via @LesEchos

  • Genopole

    23 May 2016

    RT @Biotech_finance: Biotech Finances n°724 est paru ! @cancercontrib @Genopole @matwin @innavirvax https://t.co/gGYmtj5U60 https://t.co/Wj…

  • Genopole

    23 May 2016

    RT @Paul_F_Fournier: Selon @thomsonreuters, la France est le 1er pays de l’innovation en 🇪🇺, 3e au monde ! #upupandaway #InnoGeneration htt…

  • Genopole

    23 May 2016

    RT @sup_recherche: Désir d' #Entrepreneuriat ? Osez le statut #EtudiantEntrepreneur ! https://t.co/j1iJLhY5lz

  • Global Bioenergies on track with the development schedule of its bio-isobutene production process

    Global Bioenergies, an industrial biology company developing sustainable routes to light olefins, announces significant progress in the development of its process for the production of biological (...)

  • Gene Signal and collaborators demonstrate successful activity of topical aganirsen

    Gene Signal announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drop) in two important models of retinal neovascular disease, wet age-related (...)

Sharing expertise, competencies and means

Sharing expertise, competencie

Sharing expertise, competencies and means

The Infrastructures and Platforms Department (...)


Create, Develop, Attract

Create, Develop, Attract

Create, Develop, Attract

The mission of the Genopole Enterprises team (...)